代表性成果 （论文/专利/专著等） |
1. Li Yi, Yang Bin, Ma Yanchun, Peng Xiaojun, Wang Zhiyu, Sheng Bin, Wei Zichao, Cui Yongping* and Liu Zhihua*. Phosphoproteomics reveals therapeutic targets of esophageal squamous cell carcinoma. Signal Transduction and Targeted Therapy. 2021:6:381（IF=18.005） 2. Zheng Ziliang#, Chen Xuejiao#, Ma Yanchun#, Dai Rong#, Wu Shutong, Wang Tong, Xing Jun, Gao Jinnan, and Zhang Ruiping*. Dual H2O2-Amplified Nanofactory for Simultaneous Self-Enhanced NIR-II Fluorescence Activation Imaging and Synergistic Tumor Therapy. [J]. Small, 2022, 2203531. (SCI TOP一区，IF: 15.1536) 3. Ma Yanchun#, Wang Yi#, Wang Lu, Qian Yu, Yang Jian, Kong Pengzhou, Yan Ting, Li Hongyi, Wang Fang, Cheng Xiaolong, Cui Yongping*. Triptolide prevents proliferation and migration of Esophageal Squamous Cell Cancer via MAPK/ERK signaling pathway. European Journal of Pharmacology,2019,851:43-51（IF=4.432） 4. Ma Yanchun#*, Wang Yi#, Song Bin. Griffipavixanthone induces apoptosis of human breast cancer MCF-7 cells in vitro. Breast Cancer, 2019 Mar;26(2)（IF=4.239） 5. Ma Yanchun#, Hao Sijie#, Wang Shuwen, Zhao Yuanjun, Lim Bora, Lei Ming, David J. Spector, Wafik S. El-Deiry, Zheng Siyang, Zhu Jiyue*. A Combinatory Strategy for Detection of Live CTCs Using Microfiltration and a New Telomerase-Selective Adenovirus. Molecular Cancer Therapeutics. 2015 Mar; 14(3): 835–843 （IF=6.261） |
